Join Us

As we head into 2025, private companies are once again exploring IPO opportunities after a long period of market volatility and a handful of successful IPOs in late 2024 providing renewed optimism for increased activity in the coming year. Life sciences companies face unique challenges and opportunities in preparing for a public offering, where a well-structured strategy and compelling story are critical to success.

Join Fenwick and Morgan Stanley for an insightful webinar on the current U.S. IPO landscape and its implications for life sciences companies planning a public listing. Discover key preparation strategies and learn what actions to prioritize now to be ready for the next IPO window. This event is the second in Fenwick’s three-part Pathways to Success webinar series.

About Fenwick’s Pathways to Success Series
Fenwick hosts an essential three-part webinar series designed specifically for leaders of late-stage biotech companies. This series will provide in-depth guidance on critical lifecycle moments, featuring insights from industry experts on billion-dollar acquisitions, strategic IPO planning, and emerging M&A trends set to shape 2025. Don’t miss this opportunity to prepare your company for pivotal transitions.

If you have any questions, please contact Marissa Tsang or +1 650-335-6186.

Speakers

Agenda